Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$210K Sell
184,230
-5,770
-3% -$7.09K 0.26% 49
2025
Q2
$168K Sell
190,000
-328,541
-63% -$335K 0.22% 50
2025
Q1
$513K Buy
518,541
+17,420
+3% +$24.6K 0.77% 37
2024
Q4
$842K Hold
501,121
0.83% 29
2024
Q3
$877K Buy
501,121
+40,321
+9% +$79.1K 1.11% 26
2024
Q2
$995K Buy
460,800
+4,400
+1% +$11.8K 1.32% 20
2024
Q1
$1.36M Buy
456,400
+60,400
+15% +$163K 1.33% 21
2023
Q4
$1.11M Sell
396,000
-241,103
-38% -$633K 1% 21
2023
Q3
$1.62M Buy
637,103
+306,282
+93% +$581K 1.78% 16
2023
Q2
$718K Buy
330,821
+303,781
+1,123% +$666K 0.82% 24
2023
Q1
$54.9K Buy
+27,040
New +$59.8K 0.06% 25

Other funds holding IRIX

AMH Equity's IRIX Position: Q3 2025 in Review

AMH Equity reduced its IRIDEX (IRIX) stake by 3% in Q3 2025, selling an estimated $7.09K and leaving 184,230 shares worth $210K. The position accounts for 0.26% of the portfolio, ranked #49.

AMH Equity first reported a position in IRIX in Q1 2023 and has held it in 11 quarters since. The position peaked at $1.62M in Q3 2023. 22 funds tracked by Wall St. Rank hold IRIX as of Q3 2025.

  • AMH Equity held 184,230 shares of IRIDEX worth $210K as of Q3 2025.
  • AMH Equity sold 5,770 IRIDEX shares in Q3 2025, an estimated $7.09K.
  • IRIDEX made up 0.26% of AMH Equity's portfolio in Q3 2025, its #49 holding.
  • AMH Equity first reported a position in IRIDEX in Q1 2023 and has held it in 11 quarters since.
  • AMH Equity's IRIDEX position peaked at $1.62M in Q3 2023.
  • 22 funds tracked by Wall St. Rank held IRIDEX as of Q3 2025.

Based on AMH Equity's 13F filing for Q3 2025, filed 29 Oct 2025.